Precision Genetic Testing for Safer Medication Management from Genomind
Represented by Supply Chain Butler
Genomind provides pharmacogenetic (PGx) testing and decision support tools that empower providers, caregivers, and families to make safer, more personalized treatment choices. With a simple cheek swab and the GenMedPro™ platform, Genomind reduces adverse drug reactions, improves adherence, and optimizes care across long-term care, assisted living, skilled nursing, rural providers, and direct-to-patient settings.
The Challenge in Long-Term Care Medication Management
Up to 91% of long-term care residents take 5 or more medications and 65% take 10 or more. ADRs increase exponentially with the use of 4 or more medications, and in two LTC facilities, 42% of adverse drug events were considered preventable, totaling more than 800 events. These events lead to avoidable ER visits, hospitalizations, costs, and stress for staff and families.
Genomind Delivers Personalized Precision Care
Simple, One-Time Test
Cheek swab with results processed twice at 99.9% accuracy
Covered by Medicare
National coverage through Medicare fee-for-service with no cost to the patient
Clinical Decision Support
Guides providers in choosing safer, more effective medications while minimizing trial-and-error prescribing
GenMedPro™ Platform
An interactive tool providing personalized drug recommendations in minutes, highlighting gene–drug, drug–drug, and gene–age interactions; supports over 1,000 drugs covering 99% of commonly prescribed medications
Patient & Family Reports
Clear, easy-to-understand reports that improve family engagement and confidence
Tangible Benefits for Patients, Families, Caregivers, and Providers
Patients
Fewer ADRs, faster symptom improvement, safer medication use.
Families
Peace of mind with personalized, DNA-informed medication plans
Providers
Evidence-based prescribing support, reduced liability, Medicare compliance support.
Facilities
Improved quality metrics, reduced readmissions, strengthened care outcomes
Caregivers
Simplified oversight, streamlined management of complex drug regimens
Why Providers and Families Choose Genomind
Better Outcomes
In a 6-month case-control study, Genomind patients had 40% fewer ER visits, 58% fewer hospitalizations, and saved ~$1,948 per patient
Faster Symptom Improvement
87% of patients experienced faster improvement compared with non-Genomind patients.
Improved Adherence
PGx-guided patients were more adherent to treatment
Case Example
An 81-year-old female LTC resident with severe
depression showed dramatic improvement after PGx-guided adjustments to her medication plan.
From Trial-and-Error to Precision Care.
Genomind, represented by Supply Chain Butler, provides the tools to transform medication management — from residents in skilled nursing and assisted living, to caregivers, rural providers, and even direct-to-patient testing. By reducing adverse drug events, supporting Medicare compliance, and improving outcomes, Genomind empowers the entire care team.